S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Cen...
S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study
About this item
Full title
Author / Creator
Publisher
Philadelphia, PA: Wolters Kluwer
Journal title
Language
English
Formats
Publication information
Publisher
Philadelphia, PA: Wolters Kluwer
Subjects
More information
Scope and Contents
Contents
[...]there is a significant need to prevent CVD by targeting excess adiposity in patients with obesity. Secondary outcomes included total body weight loss percentage (TBWL%) and change in blood pressure, HbA1c, fasting glucose, lipid panel, and HTN medications. The following parameters decreased significantly: blood pressure by 9.3/4.9 mmHg (n= 93;...
Alternative Titles
Full title
S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2878545691
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2878545691
Other Identifiers
ISSN
0002-9270
E-ISSN
1572-0241
DOI
10.14309/01.ajg.0000956232.19702.5a
